Normalization Cancer Immunotherapy for Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Normalization Cancer Immunotherapy for Melanoma

Published:2020-06 Issue:6 Volume:140 Page:1134-1142
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Vesely Matthew D.^ORCID,Chen Lieping^ORCID

Funder

Melanoma Research Alliance

National Institutes of Health

National Center for Advancing Translational Sciences

United Technologies

Dermatology Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference107 articles.

1. Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis;Abdel-Rahman;Future Oncol,2016

2. Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma;Agarwala;J Clin Oncol,2002

3. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma;Andtbacka;J Clin Oncol,2015

4. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial;Antonia;Lancet Oncol,2016

5. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Neoadjuvant Immunotherapy in the Management of Merkel Cell Carcinoma with Clinically Detected Regional Lymph Node Metastasis;Annals of Surgical Oncology;2024-06-01

2. Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling;Cancers;2024-05-21

3. Immune checkpoint inhibition as a therapeutic strategy for HIV eradication: current insights and future directions;Current Opinion in HIV and AIDS;2024-05-15

4. Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor Outcomes;Journal of Investigative Dermatology;2024-01

5. Current landscape and tailored management of immune-related adverse events;Frontiers in Pharmacology;2023-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3